Diagnosis and evaluation of nonalcoholic fatty liver disease

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Obika, Mikako ^a   Noguchi, Hirofumi ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA 2 MACROGLOBULIN; AMINOTRANSFERASE; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; COLLAGEN TYPE 4; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HOMOCYSTEINE; LEPTIN; LIVER ENZYME; PROCOLLAGEN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADVERSE OUTCOME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ELASTOGRAPHY; EVALUATION; FIBROSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JAUNDICE; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER CIRRHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN HOMEOSTASIS; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; TRIACYLGLYCEROL BLOOD LEVEL; BIOPSY; FATTY LIVER; INFLAMMATION; LIVER CELL; PATHOLOGY;

APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY; DIABETES MELLITUS, TYPE 2; FATTY LIVER; HEPATOCYTES; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84855171923     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/145754     Document Type: Review

References (158)

1. Ratziu V., Bellentani S., Cortez-Pinto H., Day C., Marchesini G., A position statement on NAFLD/NASH based on the EASL 2009 special conference Journal of Hepatology 2010 53 2 372 384
2. Szczepaniak L. S., Nurenberg P., Leonard D., Browning J. D., Reingold J. S., Grundy S., Hobbs H. H., Dobbins R. L., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population American Journal of Physiology 2005 288 2 E462 E468
3. Marchesini G., Brizi M., Morselli-Labate A. M., Bianchi G., Bugianesi E., McCullough A. J., Forlani G., Melchionda N., Association of nonalcoholic fatty liver disease with insulin resistance American Journal of Medicine 1999 107 5 450 455 (Pubitemid 29528333)
4. Marceau P., Biron S., Hould F. S., Marceau S., Simard S., Thung S. N., Kral J. G., Liver pathology and the metabolic syndrome X in severe obesity Journal of Clinical Endocrinology and Metabolism 1999 84 5 1513 1517 (Pubitemid 30644245)
5. Marchesini G., Brizi M., Blanchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N., Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 2001 50 8 1844 1850 (Pubitemid 33641605)
6. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 2002 106 25 3143 3421
7. Shulman A. I., Mangelsdorf D. J., Retinoid X receptor heterodimers in the metabolic syndrome The New England Journal of Medicine 2005 353 6 604 615 (Pubitemid 41138942)
8. Lewis J. R., Mohanty S. R., Nonalcoholic fatty liver disease: a review and update Digestive Diseases and Sciences 2010 55 3 560 578
9. Edmison J., McCullough A. J., Pathogenesis of non-alcoholic steatohepatitis: human data Clinics in Liver Disease 2007 11 1 75 104 (Pubitemid 46829977)
10. Wieckowska A., Feldstein A. E., Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive Seminars in Liver Disease 2008 28 4 386 395
11. Angulo P., Medical progress: nonalcoholic fatty liver disease The New England Journal of Medicine 2002 346 16 1221 1231 (Pubitemid 34984585)
12. Browning J. D., Szczepaniak L. S., Dobbins R., Nuremberg P., Horton J. D., Cohen J. C., Grundy S. M., Hobbs H. H., Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 2004 40 6 1387 1395 (Pubitemid 39657013)
13. Fan J. G., Zhu J., Li X. J., Chen L., Li L., Dai F., Li F., Chen S. Y., Prevalence of and risk factors for fatty liver in a general population of Shanghai, China Journal of Hepatology 2005 43 3 508 514 (Pubitemid 41111434)
14. Jimba S., Nakagami T., Takahashi M., Wakamatsu T., Hirota Y., Iwamoto Y., Wasada T., Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabetic Medicine 2005 22 9 1141 1145 (Pubitemid 41224170)
15. Gupte P., Amarapurkar D., Agal S., Baijal R., Kulshrestha P., Pramanik S., Patel N., Madan A., Amarapurkar A., Hafeezunnisa, Non-alcoholic steatohepatitis in type 2 diabetes mellitus Journal of Gastroenterology and Hepatology 2004 19 8 854 858 (Pubitemid 39093200)
16. Wanless I. R., Lentz J. S., Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 1990 12 5 1106 1110
17. Younossi Z. M., Gramlich T., Matteoni C. A., Boparai N., McCullough A. J., Nonalcoholic fatty liver disease in patients with type 2 diabetes Clinical Gastroenterology and Hepatology 2004 2 3 262 265 (Pubitemid 38293314)
18. Adams L. A., Harmsen S., Sauver J. L. S., Charatcharoenwitthaya P., Enders F. B., Therneau T., Angulo P., Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study American Journal of Gastroenterology 2010 105 7 1567 1573
19. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., Zenari L., Falezza G., Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 2005 54 12 3541 3546 (Pubitemid 43334347)
20. Targher G., Day C. P., Bonora E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease The New England Journal of Medicine 2010 363 14 1341 1350
21. Ghouri N., Preiss D., Sattar N., Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data Hepatology 2010 52 3 1156 1161
22. Rashid M., Roberts E. A., Nonalcoholic steatohepatitis in children Journal of Pediatric Gastroenterology and Nutrition 2000 30 1 48 53 (Pubitemid 30349945)
23. Manton N. D., Lipsett J., Moore D. J., Davidson G. P., Bourne A. J., Couper R. T. L., Non-alcoholic steatohepatitis in children and adolescents Medical Journal of Australia 2000 173 9 476 479
24. Leeds J. S., Forman E. M., Morley S., Scott A. R., Tesfaye S., Sanders D. S., Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies Diabetic Medicine 2009 26 12 1235 1241
25. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Pichiri I., Sorgato C., Zenari L., Bonora E., Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes Journal of Hepatology 2010 53 4 713 718
26. Neuschwander-Tetri B. A., Caldwell S. H., Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 2003 37 5 1202 1219 (Pubitemid 36538699)
27. Dowman J. K., Tomlinson J. W., Newsome P. N., Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Alimentary Pharmacology and Therapeutics 2011 33 5 525 540
28. Smith B. W., Adams L. A., Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment Nature Reviews Endocrinology 2011 7 8 456 465
29. Torres D. M., Harrison S. A., Diagnosis and therapy of nonalcoholic steatohepatitis Gastroenterology 2008 134 6 1682 1698 (Pubitemid 351615413)
30. Mofrad P., Contos M. J., Haque M., Sargeant C., Fisher R. A., Luketic V. A., Sterling R. K., Shiffman M. L., Stravitz R. T., Sanyal A. J., Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 2003 37 6 1286 1292 (Pubitemid 36667307)
31. Fracanzani A. L., Valenti L., Bugianesi E., Andreoletti M., Colli A., Vanni E., Bertelli C., Fatta E., Bignamini D., Marchesini G., Fargion S., Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 2008 48 3 792 798
32. Pratt D. S., Kaplan M. M., Evaluation of abnormal liver-enzyme results in asymptomatic patients The New England Journal of Medicine 2000 342 17 1266 1271 (Pubitemid 30235957)
33. Angulo P., Keach J. C., Batts K. P., Lindor K. D., Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 1999 30 6 1356 1362
34. Haring R., Wallaschofski H., Nauck M., Drr M., Baumeister S. E., Vlzke H., Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels Hepatology 2009 50 5 1403 1411
35. Ruhl C. E., Everhart J. E., Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population Gastroenterology 2009 136 2 477 485
36. Tahan V., Canbakan B., Balci H., Dane F., Akin H., Can G., Hatemi I., Olgac V., Sonsuz A., Ozbay G., Yurdakul I., Senturk H., Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk Hepato-Gastroenterology 2008 55 85 1433 1438
37. Pantsari M. W., Harrison S. A., Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase Journal of Clinical Gastroenterology 2006 40 7 633 635 (Pubitemid 44259772)
38. Sumida Y., Yoshikawa T., Okanoue T., Role of hepatic iron in non-alcoholic steatohepatitis Hepatology Research 2009 39 3 213 222
39. Diehl A. M., Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis Alcoholism 2001 25 5 8S 14S
40. Diehl A. M., Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease Clinics in Liver Disease 2004 8 3 619 638 (Pubitemid 39141146)
41. Abiru S., Migita K., Maeda Y., Daikoku M., Ito M., Ohata K., Nagaoka S., Matsumoto T., Takii Y., Kusumoto K., Nakamura M., Komori A., Yano K., Yatsuhashi H., Eguchi K., Ishibashi H., Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis Liver International 2006 26 1 39 45
42. Feldstein A. E., Werneburg N. W., Canbay A., Guicciardi M. E., Bronk S. F., Rydzewski R., Burgart L. J., Gores G. J., Free fatty acids promote hepatic lipotoxicity by stimulating TNF- expression via a lysosomal pathway Hepatology 2004 40 1 185 194 (Pubitemid 38868937)
43. Hui J. M., Hodge A., Farrell G. C., Kench J. G., Kriketos A., George J., Beyond insulin resistance in NASH: TNF- or adiponectin? Hepatology 2004 40 1 46 54 (Pubitemid 38868922)
44. Li Z., Yang S., Lin H., Huang J., Watkins P. A., Moser A. B., DeSimone C., Song X. Y., Diehl A. M., Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 2003 37 2 343 350 (Pubitemid 36152533)
45. Xu H., Teoman Uysal K., David Becherer J., Arner P., Hotamisligil G. S., Altered tumor necrosis factor- (TNF- ) processing in adipocytes and increased expression of transmembrane TNF- in obesity Diabetes 2002 51 6 1876 1883 (Pubitemid 34564301)
46. Xu A., Wang Y., Keshaw H., Xu L. Y., Lam K. S. L., Cooper G. J. S., The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice The Journal of Clinical Investigation 2003 112 1 91 100 (Pubitemid 38056380)
47. Crespo J., Cayoen A., Fernendez-Gil P., Hernndez-Guerra M., Mayorga M., Domnguez-Dez A., Fernndez-Escalante J. C., Pons-Romero F., Gene expression of tumor necrosis factor and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 2001 34 6 1158 1163 (Pubitemid 33096588)
48. Shimada M., Kawahara H., Ozaki K., Fukura M., Yano H., Tsuchishima M., Tsutsumi M., Takase S., Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis American Journal of Gastroenterology 2007 102 9 1931 1938 (Pubitemid 47301507)
49. Argentou M., Tiniakos D. G., Karanikolas M., Melachrinou M., Makri M. G., Kittas C., Kalfarentzos F., Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery Obesity Surgery 2009 19 9 1313 1323
50. Arvaniti V. A., Thomopoulos K. C., Tsamandas A., Makri M., Psyrogiannis A., Vafiadis G., Asimakopoulos S., Labropoulou-Karatza C., Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis Acta Gastro-Enterologica Belgica 2008 71 4 355 360
51. Yoneda M., Mawatari H., Fujita K., Iida H., Yonemitsu K., Kato S., Takahashi H., Kirikoshi H., Inamori M., Nozaki Y., Abe Y., Kubota K., Saito S., Iwasaki T., Terauchi Y., Togo S., Maeyama S., Nakajima A., High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH Journal of Gastroenterology 2007 42 7 573 582 (Pubitemid 47190075)
52. Targher G., Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease Journal of Hepatology 2006 45 6 879 881 (Pubitemid 44646692)
53. Hui J. M., Farrell G. C., Kench J. G., George J., High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD Hepatology 2004 39 5 1458 1459 (Pubitemid 38569072)
54. Wieckowska A., Papouchado B. G., Li Z., Lopez R., Zein N. N., Feldstein A. E., Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis American Journal of Gastroenterology 2008 103 6 1372 1379 (Pubitemid 351813900)
55. Tarantino G., Conca P., Pasanisi F., Ariello M., Mastrolia M., Arena A., Tarantino M., Scopacasa F., Vecchione R., Could inflammatory markers help diagnose nonalcoholic steatohepatitis? European Journal of Gastroenterology and Hepatology 2009 21 5 504 511
56. Lemoine M., Ratziu V., Kim M., Maachi M., Wendum D., Paye F., Bastard J. P., Poupon R., Housset C., Capeau J., Serfaty L., Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease Liver International 2009 29 9 1431 1438
57. Chalasani N., Crabb D. W., Cummings O. W., Kwo P. Y., Asghar A., Pandya P. K., Considine R. V., Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? American Journal of Gastroenterology 2003 98 12 2771 2776 (Pubitemid 38020122)
58. Uygun A., Kadayifci A., Yesilova Z., Erdil A., Yaman H., Saka M., Deveci M. S., Bagci S., Gulsen M., Karaeren N., Dagalp K., Serum leptin levels in patients with nonalcoholic steatohepatitis American Journal of Gastroenterology 2000 95 12 3584 3589
59. Chitturi S., Farrell G., Frost L., Kriketos A., Lin R., Liddle C., Samarasinghe D., George J., Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002 36 2 403 409 (Pubitemid 34810360)
60. Haukeland J. W., Dams J. K., Konopski Z., Lberg E. M., Haaland T., Goverud I., Torjesen P. A., Birkeland K., Bjro K., Aukrust P., Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 Journal of Hepatology 2006 44 6 1167 1174
61. Suzuki A., Angulo P., Lymp J., Li D., Satomura S., Lindor K., Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease Liver International 2005 25 4 779 786 (Pubitemid 41038659)
62. Parés A., Deulofeu R., Giménez A., Caballera L., Bruguera M., Caballera J., Ballesta A. M., Rodés J., Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis Hepatology 1996 24 6 1399 1403 (Pubitemid 26399038)
63. Sakugawa H., Nakayoshi T., Kobashigawa K., Yamashiro T., Maeshiro T., Miyagi S., Shiroma J., Toyama A., Nakayoshi T., Kinjo F., Saito A., Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease World Journal of Gastroenterology 2005 11 2 255 259 (Pubitemid 40125214)
64. Yoneda M., Mawatari H., Fujita K., Yonemitsu K., Kato S., Takahashi H., Kirikoshi H., Inamori M., Nozaki Y., Abe Y., Kubota K., Saito S., Iwasaki T., Terauchi Y., Togo S., Maeyama S., Nakajima A., Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage Journal of Gastroenterology 2007 42 5 375 381 (Pubitemid 47097254)
65. dos Santos V. N., Leite-Mr M. M. B., Kondo M., Martins J. R., Nader H., Lanzoni V. P., Parise E. R., Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease Brazilian Journal of Medical and Biological Research 2005 38 5 747 753 (Pubitemid 40867514)
66. Oliveira C. P. M. S., Da Costa Gayotto L. C., Tatai C., Della Bina B. I., Janiszewski M., Lima E. S., Abdalla D. S. P., Lopasso F. P., Laurindo F. R. M., Laudanna A. A., Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet Journal of Cellular and Molecular Medicine 2002 6 3 399 406 (Pubitemid 44133960)
67. Roskams T., Yang S. Q., Koteish A., Durnez A., DeVos R., Huang X., Achten R., Verslype C., Diehl A. M., Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease American Journal of Pathology 2003 163 4 1301 1311 (Pubitemid 37175079)
68. Wieckowska A., McCullough A. J., Feldstein A. E., Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future Hepatology 2007 46 2 582 589 (Pubitemid 47344794)
69. Bonnefont-Rousselot D., Ratziu V., Giral P., Charlotte F., Beucler I., Poynard T., Blood oxidative stress markers are unreliable markers of hepatic steatosis Alimentary Pharmacology and Therapeutics 2006 23 1 91 98 (Pubitemid 43381171)
70. Chalasani N., Deeg M. A., Crabb D. W., Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis American Journal of Gastroenterology 2004 99 8 1497 1502 (Pubitemid 39193189)
71. Sumida Y., Nakashima T., Yoh T., Furutani M., Hirohama A., Kakisaka Y., Nakajima Y., Ishikawa H., Mitsuyoshi H., Okanoue T., Kashima K., Nakamura H., Yodoi J., Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease Journal of Hepatology 2003 38 1 32 38 (Pubitemid 36078521)
72. Nakashima T., Sumida Y., Furutani M., Hirohama A., Okita M., Mitsuyoshi H., Itoh Y., Okanoue T., Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis Hepatology Research 2005 33 2 135 137 (Pubitemid 41799791)
73. Feldstein A. E., Canbay A., Angulo P., Taniai M., Burgart L. J., Lindor K. D., Gores G. J., Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 2003 125 2 437 443 (Pubitemid 36929425)
74. Feldstein A. E., Canbay A., Guicciardi M. E., Higuchi H., Bronk S. F., Gores G. J., Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice Journal of Hepatology 2003 39 6 978 983 (Pubitemid 37523769)
75. Feldstein A. E., Gores G. J., Apoptosis in alcoholic and nonalcoholic steatohepatitis Frontiers in Bioscience 2005 10 3 3093 3099 (Pubitemid 40910547)
76. Feldstein A. E., Werneburg N. W., Li Z., Bronk S. F., Gores G. J., Bax inhibition protects against free fatty acid-induced lysosomal permeabilization American Journal of Physiology 2006 290 6 G1339 G1346
77. Li Z., Berk M., McIntyre T. M., Gores G. J., Feldstein A. E., The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity Hepatology 2008 47 5 1495 1503 (Pubitemid 351702733)
78. Wieckowska A., Zein N. N., Yerian L. M., Lopez A. R., McCullough A. J., Feldstein A. E., In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 2006 44 1 27 33 (Pubitemid 44049136)
79. Feldstein A. E., Wieckowska A., Lopez A. R., Liu Y. C., Zein N. N., McCullough A. J., Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study Hepatology 2009 50 4 1072 1078
80. Malik R., Chang M., Bhaskar K., Nasser I., Curry M., Schuppan D., Byrnes V., Afdhal N., The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease Journal of Gastroenterology and Hepatology 2009 24 4 564 568
81. Mitry R. R., De Bruyne R., Quaglia A., Hughes R. D., Dhawan A., Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers Hepatology 2007 46 6 2047 2048
82. Papatheodoridis G. V., Hadziyannis E., Tsochatzis E., Georgiou A., Kafiri G., Tiniakos D. G., Margariti K., Manolakopoulos S., Manesis E. K., Archimandritis A. J., Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic fatty liver disease Journal of Clinical Gastroenterology 2010 44 4 e87 e95
83. Yilmaz Y., Dolar E., Ulukaya E., Akgoz S., Keskin M., Kiyici M., Aker S., Yilmaztepe A., Gurel S., Gulten M., Nak S. G., Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis World Journal of Gastroenterology 2007 13 6 837 844 (Pubitemid 46470292)
84. Tsutsui M., Tanaka N., Kawakubo M., Sheena Y., Horiuchi A., Komatsu M., Nagaya T., Joshita S., Umemura T., Ichijo T., Matsumoto A., Yoshizawa K., Aoyama T., Tanaka E., Sano K., Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels Journal of Clinical Gastroenterology 2010 44 6 440 447
85. Yilmaz Y., Systematic review: caspase-cleaved fragments of cytokeratin 18the promises and challenges of a biomarker for chronic liver disease Alimentary Pharmacology and Therapeutics 2009 30 11-12 1103 1109
86. Diab D. L., Yerian L., Schauer P., Kashyap S. R., Lopez R., Hazen S. L., Feldstein A. E., Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients Clinical Gastroenterology and Hepatology 2008 6 11 1249 1254
87. Gulsen M., Yesilova Z., Bagci S., Uygun A., Ozcan A., Ercin C. N., Erdil A., Sanisoglu S. Y., Cakir E., Ates Y., Erbil M. K., Karaeren N., Dagalp K., Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology 2005 20 9 1448 1455 (Pubitemid 43960846)
88. Kayadibi H., Gltepe M., Yasar B., Ince A. T., Ozcan O., Ipcioglu O. M., Kurdas O. O., Bolat B., Benek Y. Z., Guveli H., Atalay S., Ozkara S., Keskin O., Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis Digestive Diseases and Sciences 2009 54 8 1764 1771
89. Yoneda M., Uchiyama T., Kato S., Endo H., Fujita K., Yoneda K., Mawatari H., Iida H., Takahashi H., Kirikoshi H., Inamori M., Nozaki Y., Kobayashi N., Kubota K., Saito S., Maeyama S., Sagara M., Aburatani H., Kodama T., Nakajima A., Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH) BMC Gastroenterology 2008 8, article 53
90. Tarantino G., Conca P., Coppola A., Vecchione R., Di Minno G., Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis The European Journal of Clinical Investigation 2007 37 1 48 53 (Pubitemid 44934772)
91. Kotronen A., Peltonen M., Hakkarainen A., Sevastianova K., Bergholm R., Johansson L. M., Lundbom N., Rissanen A., Ridderstrle M., Groop L., Orho-Melander M., Yki-Jrvinen H., Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors Gastroenterology 2009 137 3 865 872
92. Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A., Tiribelli C., The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterology 2006 6, article 33
93. Bedogni G., Kahn H. S., Bellentani S., Tiribelli C., A simple index of lipid overaccumulation is a good marker of liver steatosis BMC Gastroenterology 2010 10, article 98
94. Petta S., Amato M., Cabibi D., Camm C., Di Marco V., Giordano C., Galluzzo A., Crax A., Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1 Hepatology 2010 52 5 1543 1552
95. Dixon J. B., Bhathal P. S., O'Brien P. E., Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 2001 121 1 91 100 (Pubitemid 32591518)
96. Palekar N. A., Naus R., Larson S. P., Ward J., Harrison S. A., Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease Liver International 2006 26 2 151 156
97. Gholam P. M., Flancbaum L., MacHan J. T., Charney D. A., Kotler D. P., Nonalcoholic fatty liver disease in severely obese subjects American Journal of Gastroenterology 2007 102 2 399 408 (Pubitemid 46160554)
98. Poynard T., Ratziu V., Charlotte F., Messous D., Munteanu M., Imbert-Bismut F., Massard J., Bonyhay L., Tahiri M., Thabut D., Cadranel J. F., Le Bail B., de Ledinghen V., Grimaldi A., Giral P., Bruckert E., Turpin G., Heurtier A., Gombert S., Lamaison F., Moussalli J., Le Calvez S., Benhamou Y., D'Arrondel C., Cocaul A., Ravalet I., Combet S., Podevin P., Basdevant A., Slama G., Clement K., Serfaty L., Housset C., Capeau J., Blanchi A., Pilette C., Bourlire M., Ouls V., Renou C., Capron D., Oberti F., Cals P., Tran A., Gelsi E., Gournay J., Vallet-Pichard A., Pol S., Causse X., Diagnostic value of biochemical markers (Nash Test) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease BMC Gastroenterology 2006 6, article 34
99. Ratziu V., Massard J., Charlotte F., Messous D., Imbert-Bismut F., Bonyhay L., Tahiri M., Munteanu M., Thabut D., Cadranel J. F., Le Bail B., de Ledinghen V., Poynard T., Grimaldi A., Giral P., Bruckert E., Turpin G., Heurtier A., Gombert S., Lamaison F., Moussalli J., Le Galvez S., Benhamou Y., D'Arrondel C., Cocaul A., Ravalet I., Combet S., Podevin P., Basdevant A., Slama G., Clement K., Serfaty L., Housset C., Capeau J., Blanchi A., Pilette C., Bourlire M., Ouls V., Renou C., Capron D., Oberti F., Cals P., Tran A., Gelsi E., Gournay J., Vallet-Pichard A., Pol S., Causse X., Diagnostic value of biochemical markers (Fibro Test-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease BMC Gastroenterology 2006 6, article 6
100. Angulo P., Hui J. M., Marchesini G., Bugianesi E., George J., Farrell G. C., Enders F., Saksena S., Burt A. D., Bida J. P., Lindor K., Sanderson S. O., Lenzi M., Adams L. A., Kench J., Therneau T. M., Day C. P., The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 2007 45 4 846 854 (Pubitemid 46631552)
101. McPherson S., Stewart S. F., Henderson E., Burt A. D., Day C. P., Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease Gut 2010 59 9 1265 1269
102. Cals P., Lainé F., Boursier J., Deugnier Y., Moal V., Oberti F., Hunault G., Rousselet M. C., Hubert I., Laafi J., Ducluzeaux P. H., Lunel F., Comparison of blood tests for liver fibrosis specific or not to NAFLD Journal of Hepatology 2009 50 1 165 173
103. Musso G., Gambino R., Cassader M., Pagano G., Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine. In press
104. Rosenberg W. M. C., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., Hubscher S., Roskams T., Pinzani M., Arthur M. J. P., Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 2004 127 6 1704 1713 (Pubitemid 39575849)
105. Guha I. N., Parkes J., Roderick P., Chattopadhyay D., Cross R., Harris S., Kaye P., Burt A. D., Ryder S. D., Aithal G. P., Day C. P., Rosenberg W. M., Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers Hepatology 2008 47 2 455 460 (Pubitemid 351280713)
106. Harrison S. A., Oliver D., Arnold H. L., Gogia S., Neuschwander-Tetri B. A., Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 2008 57 10 1441 1447
107. Ruffillo G., Fassio E., Alvarez E., Landeira G., Longo C., Domnguez N., Gualano G., Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease Journal of Hepatology 2011 54 1 160 163
108. Wai C. T., Greenson J. K., Fontana R. J., Kalbfleisch J. D., Marrero J. A., Conjeevaram H. S., Lok A. S. F., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 2003 38 2 518 526 (Pubitemid 36919874)
109. Loaeza-del-Castillo A., Paz-Pineda F., Oviedo-Crdenas E., Snchez-vila F., Vargas-Vorckov F., AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis Annals of Hepatology 2008 7 4 350 357
110. Fujii H., Enomoto M., Fukushima W., Ohfuji S., Mori M., Kobayashi S., Iwai S., Morikawa H., Tamori A., Sakaguchi H., Ikura Y., Ueda M., Kawada N., Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis Journal of Gastroenterology 2009 44 6 608 614
111. Williams A. L. B., Hoofnagle J. H., Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis Gastroenterology 1988 95 3 734 739
112. Neuschwander-Tetri B. A., Clark J. M., Bass N. M., Van Natta M. L., Unalp-Arida A., Tonascia J., Zein C. O., Brunt E. M., Kleiner D. E., McCullough A. J., Sanyal A. J., Diehl A. M., Lavine J. E., Chalasani N., Kowdley K. V., Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease Hepatology 2010 52 3 913 924
113. Vallet-Pichard A., Mallet V., Nalpas B., Verkarre V., Nalpas A., Dhalluin-Venier V., Fontaine H., Pol S., FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest Hepatology 2007 46 1 32 36 (Pubitemid 47171918)
114. Shah A. G., Lydecker A., Murray K., Tetri B. N., Contos M. J., Sanyal A. J., Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease Clinical Gastroenterology and Hepatology 2009 7 10 1104 1112
115. Cals P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M. C., Konaté A., Gallois Y., Ternisien C., Chevallier A., Lunel F., A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 2005 42 6 1373 1381 (Pubitemid 43260040)
116. Saadeh S., Younossi Z. M., Remer E. M., Gramlich T., Ong J. P., Hurley M., Mullen K. D., Cooper J. N., Sheridan M. J., The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 2002 123 3 745 750 (Pubitemid 34977081)
117. Marrero J. A., Fontana R. J., Su G. L., Conjeevaram H. S., Emick D. M., Lok A. S., NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 2002 36 6 1349 1354 (Pubitemid 35403524)
118. Osawa H., Mori Y., Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes Journal of Clinical Ultrasound 1996 24 1 25 29 (Pubitemid 26005173)
119. Sanyal A. J., AGA technical review on nonalcoholic fatty liver disease Gastroenterology 2002 123 5 1705 1725 (Pubitemid 35231670)
120. Palmentieri B., de Sio I., La Mura V., Masarone M., Vecchione R., Bruno S., Torella R., Persico M., The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis Digestive and Liver Disease 2006 38 7 485 489 (Pubitemid 44356237)
121. Strauss S., Gavish E., Gottlieb P., Katsnelson L., Interobserver and intraobserver variability in the sonographic assessment of fatty liver American Journal of Roentgenology 2007 189 6 W320 W323
122. Ryan C. K., Johnson L. A., Germin B. I., Marcos A., One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation Liver Transplantation 2002 8 12 1114 1122 (Pubitemid 35469871)
123. Mottin C. C., Moretto M., Padoin A. V., Swarowsky A. M., Toneto M. G., Glock L., Repetto G., The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients Obesity Surgery 2004 14 5 635 637 (Pubitemid 38716583)
124. Iijima H., Moriyasu F., Tsuchiya K., Suzuki S., Yoshida M., Shimizu M., Sasaki S., Nishiguchi S., Maeyama S., Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis Hepatology Research 2007 37 9 722 730 (Pubitemid 47054778)
125. Iijima H., Moriyasu F., Miyahara T., Yanagisawa K., Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies Hepatology Research 2006 35 4 235 237 (Pubitemid 44138489)
126. Jacobs J. E., Birnbaum B. A., Shapiro M. A., Langlotz C. P., Slosman F., Rubesin S. E., Horii S. C., Diagnostic criteria for fatty infiltration of the liver on contrast- enhanced helical CT American Journal of Roentgenology 1998 171 3 659 664 (Pubitemid 28406126)
127. Piekarski J., Goldberg H. I., Royal S. A., Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease Radiology 1980 137 3 727 729 (Pubitemid 11203707)
128. Kodama Y., Ng C. S., Wu T. T., Ayers G. D., Curley S. A., Abdalla E. K., Vauthey J. N., Charnsangavej C., Comparison of CT methods for determining the fat content of the liver American Journal of Roentgenology 2007 188 5 1307 1312 (Pubitemid 46668513)
129. Park S. H., Kim P. N., Kim K. W., Lee S. W., Yoon S. E., Park S. W., Ha H. K., Lee M. G., Hwang S., Lee S. G., Yu E. S., Cho E. Y., Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment Radiology 2006 239 1 105 112
130. Ricci C., Longo R., Gioulis E., Bosco M., Pollesello P., Masutti F., Croc L. S., Paoletti S., Bernard B. D., Tiribelli C., Palma L. D., Noninvasive in vivo quantitative assessment of fat content in human liver Journal of Hepatology 1997 27 1 108 113 (Pubitemid 27357063)
131. Hamer O. W., Aguirre D. A., Casola G., Sirlin C. B., Imaging features of perivascular fatty infiltration of the liver: initial observations Radiology 2005 237 1 159 169 (Pubitemid 41346160)
132. Mazhar S. M., Shiehmorteza M., Sirlin C. B., Noninvasive assessment of hepatic steatosis Clinical Gastroenterology and Hepatology 2009 7 2 135 140
133. Schwenzer N. F., Springer F., Schraml C., Stefan N., Machann J., Schick F., Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance Journal of Hepatology 2009 51 3 433 445
134. Mendler M. H., Bouillet P., Sidaner A. L., Lavoine E., Labrousse F., Sautereau D., Pillegand B., Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload Journal of Hepatology 1998 28 5 785 794 (Pubitemid 28223482)
135. Fishbein M., Castro F., Cheruku S., Jain S., Webb B., Gleason T., Stevens W. R., Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound Journal of Clinical Gastroenterology 2005 39 7 619 625 (Pubitemid 41061269)
136. Longo R., Pollesello P., Ricci C., Masutti F., Kvam B. J., Bercich L., Croc L. S., Grigolato P., Paoletti S., de Bernard B., Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis Journal of Magnetic Resonance Imaging 1995 5 3 281 285
137. Yoneda M., Fujita K., Inamori M., Nakajima A., Yoneda M., Tamano M., Hiraishi H., Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) Gut 2007 56 9 1330 1331 (Pubitemid 47300449)
138. Wong V. W. S., Vergniol J., Wong G. L. H., Foucher J., Chan H. L. Y., Le Bail B., Choi P. C. L., Kowo M., Chan A. W. H., Merrouche W., Sung J. J. Y., De edinghen V., Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 2010 51 2 454 462
139. Hbscher S. G., Histological assessment of non-alcoholic fatty liver disease Histopathology 2006 49 5 450 465
140. Ong J. P., Younossi Z. M., Approach to the diagnosis and treatment of nonalcoholic fatty liver disease Clinics in Liver Disease 2005 9 4 617 634 (Pubitemid 41406391)
141. Adams L. A., Angulo P., Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease Clinics in Liver Disease 2007 11 1 25 35 (Pubitemid 46829969)
142. Van Ness M. M., Diehl A. M., Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Annals of Internal Medicine 1989 111 6 473 478 (Pubitemid 19231304)
143. Oh M. K., Winn J., Poordad F., Review article: diagnosis and treatment of non-alcoholic fatty liver disease Alimentary Pharmacology and Therapeutics 2008 28 5 503 522
144. Brunt E. M., Janney C. G., Di Bisceglie A. M., Neuschwander-Tetri B. A., Bacon B. R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions American Journal of Gastroenterology 1999 94 9 2467 2474 (Pubitemid 29420675)
145. Sanyal A. J., Campbell-Sargent C., Mirshahi F., Rizzo W. B., Contos M. J., Sterling R. K., Luketic V. A., Shiffman M. L., Clore J. N., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 2001 120 5 1183 1192 (Pubitemid 32246672)
146. Adams L. A., Lymp J. F., Sauver J. S., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P., The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 2005 129 1 113 121 (Pubitemid 41002048)
147. Caldwell S. H., Oelsner D. H., Iezzoni J. C., Hespenheide E. E., Battle E. H., Driscoll C. J., Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 1999 29 3 664 669 (Pubitemid 29109578)
148. Powell E. E., Cooksley W. G. E., Hanson R., Searle J., Halliday J. W., Powell L. W., The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 1990 11 1 74 80 (Pubitemid 20075105)
149. Poonawala A., Nair S. P., Thuluvath P. J., Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 2000 32 4 689 692
150. Bugianesi E., Review article: steatosis, the metabolic syndrome and cancer Alimentary Pharmacology and Therapeutics, Supplement 2005 22 2 40 43 (Pubitemid 41564381)
151. Bullock R. E., Zaitoun A. M., Aithal G. P., Ryder S. D., Beckingham I. J., Lobo D. N., Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma Journal of Hepatology 2004 41 4 685 686 (Pubitemid 39297808)
152. Paradis V., Zalisnski S., Chelbi E., Guedj N., Degos F., Vilgrain V., Bedossa P., Belghiti J., Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liverfibrosis: a pathological analysis Hepatology 2009 49 3 851 859
153. Harrison S. A., Brunt E. M., Goodman Z. D., Di Bisceglie A. M., Diabetic hepatosclerosis: diabetic microangiopathy of the liver Archives of Pathology and Laboratory Medicine 2006 130 1 27 32 (Pubitemid 43077231)
154. Kleiner D. E., Brunt E. M., Van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y. C., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J., Sanyal A. J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 2005 41 6 1313 1321 (Pubitemid 40770284)
155. Brunt E. M., Kleiner D. E., Wilson L. A., Belt P., Neuschwander-Tetri B. A., Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 2011 53 3 810 820
156. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., Grimaldi A., Capron F., Poynard T., Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 2005 128 7 1898 1906 (Pubitemid 40824701)
157. Janiec D. J., Jacobson E. R., Freeth A., Spaulding L., Blaszyk H., Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies Obesity Surgery 2005 15 4 497 501 (Pubitemid 40605072)
158. Younossi Z. M., Gramlich T., Yao C. L., Matteoni C., Petrelli M., Goldblum J., Rybicki L., McCullough A. J., Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations Modern Pathology 1998 11 6 560 565 (Pubitemid 28280720)